Author

E. Olivetta

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

a. giovannelli· 2 shared C. Chiozzini· 2 shared F. Ferrantelli· 2 shared F. Manfredi· 2 shared M. Federico· 2 shared P. Leone· 2 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

a. giovannelli

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

CD8+ T cell immunogenicity induced by endogenous EVs engineered by antigens fused to a truncated Nefmut EV-anchoring protein

C. Chiozzini, F. Manfredi, F. Ferrantelli, P. Leone, a. giovannelli, E. Olivetta, M. Federico

This study shows that truncating the C-terminus of Nefmut does not reduce its ability to anchor antigens to EVs or induce CD8+ T cell immunity.

bioRxiv · Feb 5, 2021 · PreprintBioengineering

Long-term antitumor CD8+ T cell immunity induced by endogenously engineered extracellular vesicles

F. Ferrantelli, F. Manfredi, C. Chiozzini, E. Olivetta, A. Giovannelli, P. Leone, M. Federico

This paper demonstrates that engineered extracellular vesicles can induce long-term antitumor CD8+ T cell immunity against HPV16, effectively curing tumors and preventing relapse.

bioRxiv · Feb 5, 2021Cancer Biology